Coronavirus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Protection Against Severe Coronavirus Disease 2019 in Patients With Multiple Sclerosis Stratified According to Disease Modifying Treatment
Condition: Multiple Sclerosis Intervention: Sponsor: National MS Center Melsbroek Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2023 Category: Research Source Type: clinical trials

Assessment of Long-term Sequelae of Coronavirus Disease 2019 (COVID-19) Pneumonia With Chest CT and Pulmonary Function Tests
Conditions: COVID-19 Pneumonia; Sequelae of; Infection; Respiratory Function Impaired; SARS CoV 2 Infection; SARS-CoV 2 Pneumonia Intervention: Sponsors: Centro Hospitalar Universitario do Algarve; Universidade do Algarve Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2023 Category: Research Source Type: clinical trials

A Randomized, Double-Blind, Placebo-Controlled Phase 2/3 Study to Determine the Safety and Effectiveness of Azeliragon in the Treatment of Patients Hospitalized for Coronavirus Disease 2019 (COVID-19)
Condition: COVID-19 Interventions: Drug: Azeliragon; Drug: Placebo Sponsor: Salim S. Hayek Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2023 Category: Research Source Type: clinical trials

Post-Coronavirus Disease of 2019 (COVID-19) Rehabilitation Clinics in Saudi Arabia
Conditions: Fatigue; Cardiopulmonary Arrest; Physical Inactivity; Muscle Weakness; Stress, Emotional; Dyspnea Intervention: Other: Physical Therapy Rehabilitation Sponsors: Majmaah University; King Fahad Medical City Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2023 Category: Research Source Type: clinical trials